Women with hypothyroidism receiving levothyroxine treatment have similar cardiovascular disease risk as those without thyroid disease, according to data published in Thyroid. In an analysis of 2,647 ...
Experts discuss atherosclerotic cardiovascular disease and aortic stenosis, as well as their burden, highlighting their prevalence, impact on patient health, and the growing need for effective ...
Young women with a prior diagnosis of cervical high-grade squamous intraepithelial lesion may experience increased risk for ...
In an analysis spanning 33 years, cardiovascular diseases (CVDs) remained the leading cause of disease burden and deaths globally, with nearly 80% of the burden being attributable to modifiable risk ...
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...
Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results